Login to CE Catalog

Now viewing a program in: CE Catalog \ CE On-Demand
Autism Spectrum Disorder: What to Expect from Medication Trials
Published by The Pediatric Pharmacy Association and Ohio Pharmacists Association

Dr. Julie Dopheide, PharmD, BCPP, FASHP will conduct a 1 hour knowledge-based continuing education webinar program on Autism Spectrum Disorder. According to the Centers for Disease Control in 2018, the prevalence of Autism Spectrum Disorder is estimated at 1-2%, a dramatic increase over the past decade. The increase in prevalence is likely due to the wide range of clinical presentations and severity of symptoms ranging from mild to severe. Clinical variability and an array of co-occurring conditions ranging from ADHD, to OCD, to epilepsy, present pharmacotherapeutic challenges. This program will provide practical, evidence-based recommendations for the use of psychotropic medications in children and adolescents with autism spectrum disorder.

Learning Objectives:
At the end of this session, participants will be able to:
1. Given a specific case of a child or adolescent with Autism Spectrum Disorder (ASD), determine when an antipsychotic is warranted and recommend monitoring parameters to ensure safety.
2. Compare ADHD treatments with regard to safety, efficacy, and dosing recommendations for children with ASD.
3. Provide recommendations on the safe and effective use of antidepressants for youth with ASD.
4. Counsel a parent or family member on realistic expectations from psychotropics and complementary treatments for autism spectrum disorder.

ACPE logo PPAG has accredited this knowledge-based webinar for 1.0 contact hours (0.10 CEUs) of continuing education credit for pharmacists. UAN #: 0180-0000-19-007-L01-P

The Pediatric Pharmacy Advocacy Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to receive credit, participants must register for the program, attend the program, and fill out a post-program survey. Webinar programs are 100% supported through program registration fees and PPAG membership dues, and is not supported by Industry.

Group Pricing: Group pricing is available through online registration for CE ONLY. Groups will need to email Lauren Henretty at lhenretty@pediatricpharmacy.org their attendance list with each participants name, email, NABP# and DOB in order to receive credit.

Dr. Julie Dopheide, PharmD, BCPP, FASHP
Residency Program Director - University of Southern California's PGY2 Psychiatric Pharmacy
Dr. Dopheide is a board certified psychiatric pharmacist who provides clinical service for adults and children with psychiatric illness at Los Angeles County + USC Medical Center. She is the University of Southern California's PGY2 Psychiatric Pharmacy residency program director and supervises the resident in the provision of comprehensive medication management on the inpatient psychiatry service and clinics. She is actively involved in teaching pharmacy students, medical students, allied...More
Originally Published
June 12, 2019

Program Titles and Supporting Materials
This program contains the following components:
  1. Autism Spectrum Disorder: What to Expect from Medication Trials - Video
  2. Autism Spectrum Disorder: What to Expect from Medication Trials - Paper

How To Attend
Join the self-paced program from your office, home, or hotel room using a computer and high speed internet connection. You may start and stop the program at your convenience, continue where you left off, and review supporting materials as often as you like. Please note: Internet Explorer is no longer a supported browser. We recommend using Google Chrome, Mozilla Firefox or Safari for best results.

Technical Requirements
You may access this course on a computer or mobile device with high speed internet (iPhones require iOS 10 or higher). Recommended browsers are Google Chrome or Mozilla Firefox.

If applicable, you may obtain credit in multiple jurisdictions simultaneously for this program (see pending/approved list below). If electing credit for this program, registrants in jurisdictions not listed below will receive a Certificate of Completion that may or may not meet credit requirements in other jurisdictions. Where applicable, credit will be only awarded to a paid registrant completing all the requirements of the program as determined by the selected accreditation authority.

 Click on jurisdiction for specific details  

You May Also Be Interested In...
On-Demand Programs
Evidence Based Pharmacotherapy of Pediatric Traumatic Brain Injury (Credit: ACPE (Pharmacists))
Published on 6/10/2020
Fanning the Inflammatory Flame: Inflammatory Biomarkers in Pediatrics (Credit: ACPE (Pharmacists), BCPPS)
Published on 5/27/2020
There’s More Than Just CBD: Updates in the Management of Seizures in Children (Credit: ACPE (Pharmacists))
Published on 11/13/2019
Management of Loperamide Toxicity and Cannabinoid Hyperemesis Syndrome in Pediatric Patients (Credit: ACPE (Pharmacists))
Published on 10/30/2019
Need Some Insulin? K! Managing Pediatric DKA (Credit: ACPE (Pharmacists))
Published on 9/4/2019
The Wheezy Truth: the do’s and don’ts to managing acute pediatric asthma in the ED (Credit: ACPE (Pharmacists))
Published on 8/7/2019
New Tools and Concepts for Antibiotic Stewardship (Credit: ACPE (Pharmacists))
Published on 4/3/2019
SMOF, Omegaven, or Intralipid - Which one for PNALD, BPD, ROP (Credit: ACPE (Pharmacists))
Published on 1/23/2019
New Therapies & Controversies in Chronic Kidney Disease Management
Published on 5/24/2017
Refund Policy
SeminarWeb and Ohio Pharmacists Association programs are non-refundable.

Privacy Statement
We respect and are committed to protecting your privacy. (Read Statement)

Powered by
Powered by SeminarWeb.com